Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Toxicology and Applied Pharmacology

• Publication date

  2009-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.taap.2009.02.026PMID 19285099
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease.

  2007cited by this paper
• Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.

  2007cited by this paper
• Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases

  2007cited by this paper
• Minocycline modulates neuroinflammation independently of its antimicrobial activity in staphylococcus aureus-induced brain abscess.

  2007cited by this paper
• Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke

  2006cited by this paper
• Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation

  2006cited by this paper
• Deletion of Mtgr1 sensitizes the colonic epithelium to dextran sodium sulfate-induced colitis.

  2006cited by this paper
• Collagenase-3 (MMP-13) expression by inflamed mucosa in inflammatory bowel disease

  2006cited by this paper
• Antimicrobials in the Management of Inflammatory Bowel Disease

  2006cited by this paper
• Role of Matrix Metalloproteinases in Intestinal Inflammation

  2006cited by this paper
• Evolving knowledge and therapy of inflammatory bowel disease

  2006cited by this paper
• Tetracyclines: nonantibiotic properties and their clinical implications.

  2006cited by this paper
• Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production.

  2006cited by this paper
• Matrix metalloproteinase‐9 modulates intestinal injury in rats with transmural colitis

  2006cited by this paper
• Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor‐α

  2006cited by this paper
• Dose–Response Effect of Tetracyclines on Cerebral Matrix Metalloproteinase-9 after Vascular Endothelial Growth Factor Hyperstimulation

  2006cited by this paper
• Immunity, Inflammation, and Allergy in the Gut

  2005cited by this paper
• Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP.

  2005cited by this paper
• Minocycline reduces renal microvascular leakage in a rat model of ischemic renal injury.

  2005cited by this paper
• Minocycline Protects against Permanent Cerebral Ischemia in Wild Type but Not in Matrix Metalloprotease-9-Deficient Mice

  2005cited by this paper
• Effects of minocycline on Fas‐mediated fulminant hepatitis in mice

  2005cited by this paper
• Role of matrix metalloproteinases in inflammatory bowel disease.

  2005cited by this paper
• Resistance of Collagenase-2 (Matrix Metalloproteinase-8)-Deficient Mice to TNF-Induced Lethal Hepatitis1

  2005cited by this paper
• An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice

  2004cited by this paper
• Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn’s disease

  2004cited by this paper
• Minocycline in Huntington's disease: A pilot study

  2004cited by this paper
• Paradoxical roles of different nitric oxide synthase isoforms in colonic injury.

  2004cited by this paper
• Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics.

  2004cited by this paper
• Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis.

  2003cited by this paper
• Increased activity and expression of matrix metalloproteinase-9 in a rat model of distal colitis.

  2003cited by this paper
• The immunological and genetic basis of inflammatory bowel disease

  2003cited by this paper
• Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity.

  2003cited by this paper
• Nitric Oxide in Inflammatory Bowel Disease

  2003cited by this paper
• Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice.

  2002cited by this paper
• Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency

  2002cited by this paper
• Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post‐translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis

  2002cited by this paper
• Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

  2002cited by this paper
• Gelatinase B deficiency protects against endotoxin shock

  2002cited by this paper
• Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

  2001cited by this paper
• Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis.

  2001cited by this paper
• Different Subsets of Enteric Bacteria Induce and Perpetuate Experimental Colitis in Rats and Mice

  2001cited by this paper
• N-(3-(aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats.

  2001cited by this paper
• Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine.

  2001cited by this paper
• Invasive pulmonary aspergillosis associated with infliximab therapy.

  2001cited by this paper
• Colon epithelial cell death in 2,4,6-trinitrobenzenesulfonic acid-induced colitis is associated with increased inducible nitric-oxide synthase expression and peroxynitrite production.

  2001cited by this paper
• Regulation of Murine Intestinal Inflammation by Reactive Metabolites of Oxygen and Nitrogen

  2001cited by this paper
• Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

  2001cited by this paper
• Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

  2001cited by this paper
• Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone.

  2001cited by this paper
• Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

  2000cited by this paper
• Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease

  2000cited by this paper
• Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease

  2000cited by this paper
• Matrix metalloproteinase levels are elevated in inflammatory bowel disease.

  1999cited by this paper
• Interferon‐gamma (IFN‐γ)‐ and tumour necrosis factor (TNF)‐induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)‐induced colitis in mice

  1999cited by this paper
• Reduced oxidative and nitrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase

  1999cited by this paper
• Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice

  1998cited by this paper
• Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sodium sulfate injury in mice.

  1998cited by this paper
• Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis.

  1998cited by this paper
• Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis.

  1998cited by this paper
• Post‐transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines

  1997cited by this paper
• The Influence of Transforming Growth Factor β1 on the Expression of Genes Coding for Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases During Regeneration from Cerulein‐Induced Pancreatitis

  1997cited by this paper
• Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice.

  1997cited by this paper
• A novel mechanism of action of tetracyclines: effects on nitric oxide synthases.

  1996cited by this paper
• Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen.

  1996cited by this paper
• Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.

  1996cited by this paper
• Experimental models of inflammatory bowel disease.

  1995cited by this paper
• The influence of tetracyclines on T cell activation

  1995cited by this paper
• Frequency of glucocorticoid resistance and dependency in Crohn's disease.

  1994cited by this paper
• Pathological and Therapeutic Implications for Nitric Oxide in Inflammatory Bowel Disease

  1994cited by this paper
• Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice.

  1994cited by this paper
• Blocking Periodontal Disease Progression by Inhibiting Tissue-Destructive Enzymes: A Potential Therapeutic Role for Tetracyclines and Their Chemically-Modified Analogs.

  1993cited by this paper
• Measurement of nitric oxide in biological models

  1993cited by this paper
• Clinicopathologic study of dextran sulfate sodium experimental murine colitis.

  1993cited by this paper
• Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.

  1993cited by this paper
• Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: a potential therapeutic role for tetracyclines and their chemically-modified analogs.

  1993cited by this paper
• Angiogenesis inhibition by minocycline.

  1991cited by this paper
• A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.

  1990cited by this paper
• A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice

  1990cited by this paper
• Hapten-induced model of chronic inflammation and ulceration in the rat colon.

  1989cited by this paper
• Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker.

  1982cited by this paper
• PROTECTIVE. EFFECT OF METRONIDAZOLE IN EXPERIMENTALULCERATIVE COLITIS

  1978cited by this paper
• Protective effect of metronidazole in experimental ulcerative colitis.

  1978cited by this paper
• Cortisone in Ulcerative Colitis

  1954cited by this paper
• GASTROENTEROLOGY 2006;130:2060–2073 Angiogenesis as a Novel Component of Inflammatory Bowel Disease Pathogenesis

  year unknowncited by this paper

• Alternative Therapeutic Potential of Antibiotics Inhibiting Bacterial Translation as Regulators of Mitochondrial Dysfunction

  2025cites this paper
• Repurposing minocycline as an added-on treatment for ulcerative colitis patients on mesalamine: a randomized clinical pilot study

  2025influential citation
• Targeted microbiota dysbiosis repair: An important approach to health management after spinal cord injury.

  2024cites this paper
• Transabdominal ultrasound alleviates LPS-induced neuroinflammation by modulation of TLR4/NF-κB signaling and tight junction protein expression.

  2023cites this paper
• Gut-brain axis interacts with immunomodulation in inflammatory bowel disease.

  2023cites this paper
• The anti-inflammatory effects of minocycline on lipopolysaccharide-induced paw oedema in rats: a histopathological and molecular study

  2023cites this paper
• Minocycline synergizes with corticosteroids in reducing colitis severity in mice via the modulation of pro-inflammatory molecules

  2023cites this paper
• Gut Microbiome and Neuroinflammation in Hypertension

  2022cites this paper
• Glial Cells in Glaucoma: Friends, Foes, and Potential Therapeutic Targets

  2021cites this paper
• Effects of crystalline penicillin G sodium on human T-cells differentiation

  2021cites this paper
• Digestive Inflammation: Role of Proteolytic Dysregulation

  2021cites this paper
• Immunotherapy of Autoimmune Diseases with Nonantibiotic Properties of Tetracyclines

  2020cites this paper
• Minocycline in Treating Glioblastoma Multiforme: Far beyond a Conventional Antibiotic

  2020cites this paper
• Interventions of natural and synthetic agents in inflammatory bowel disease, modulation of nitric oxide pathways

  2020cites this paper
• Anti-inflammatory and antiviral effects of minocycline in enterovirus 71 infections.

  2019cites this paper
• The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics.

  2018cites this paper
• Anticonvulsant effect of minocycline on pentylenetetrazole-induced seizure in mice: involvement of nitric oxide and N-methyl-d-aspartate receptor.

  2018cites this paper
• Immunomodulatory tetracyclines ameliorate DNBS‐colitis: Impact on microRNA expression and microbiota composition

  2018cites this paper
• Immunomodulatory tetracyclines shape the intestinal inflammatory response inducing mucosal healing and resolution

  2018cites this paper
• Gelatin tannate and tyndallized probiotics: a novel approach for treatment of diarrhea.

  2017cites this paper
• Immunomodulatory tetracyclines: Facing the complexity of intestinal inflammation

  2017influential citation
• Asymmetric Collagen/chitosan Membrane Containing Minocycline-loaded Chitosan Nanoparticles for Guided Bone Regeneration

  2016cites this paper
• Neonatal hyperbilirubinemia : in vivo characterization of mechanisms of bilirubin neurotoxicity and pharmacological treatments

  2016cites this paper
• Ameliorative Potential of Minocycline and/or Lactulose on Experimentally Induced Colitis

  2016cites this paper
• Minocycline attenuates cardiac dysfunction in tumor-burdened mice.

  2016cites this paper
• The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases

  2016cites this paper
• Matrix Metalloproteinases in Inflammatory Bowel Disease: An Update

  2015cites this paper
• Minocycline inhibits peritoneal macrophages but activates alveolar macrophages in acute pancreatitis

  2015cites this paper
• The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors.

  2015cites this paper
• A new therapeutic association to manage relapsing experimental colitis: Doxycycline plus Saccharomyces boulardii.

  2015cites this paper
• MMP-19 deficiency causes aggravation of colitis due to defects in innate immune cell function

  2015cites this paper
• Gastroprotective effect of minocycline in experimentally induced gastric ulcers in rats.

  2014cites this paper
• Minocycline, A Tetracycline Derivative, as a Potential Protective Agent for Acute Stroke

  2014cites this paper
• Involvement of nitric oxide with activation of Toll-like receptor 4 signaling in mice with dextran sodium sulfate-induced colitis.

  2014cites this paper
• Fragile X Syndrome: from molecular pathology to therapy.

  2014cites this paper
• Anti-inflammatory Actions of Adjunctive Tetracyclines and Other Agents in Periodontitis and Associated Comorbidities

  2014cites this paper
• Is there new hope for therapeutic matrix metalloproteinase inhibition?

  2014cites this paper
• Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for ‘gut barrier protectors’ in IBD?

  2014cites this paper
• Bioinformatics analyses reveal age-specific neuroimmune modulation as a target for treatment of high ethanol drinking.

  2014cites this paper
• Use of artificial cell microcapsule containing thalidomide for treating TNBS-induced Crohn's disease in mice.

  2014cites this paper
• Minocycline attenuates HIV‐1 infection and suppresses chronic immune activation in humanized NOD/LtsZ‐scidIL‐2Rγnull mice

  2014cites this paper
• Minocycline ameliorates lung and liver dysfunction in a rodent model of hemorrhagic shock/resuscitation plus abdominal compartment syndrome.

  2013cites this paper
• A new face for old antibiotics: tetracyclines in treatment of amyloidoses.

  2013cites this paper
• Minocycline: far beyond an antibiotic

  2013cites this paper
• ANTI-INFLAMMATORY POTENTIAL OF ARTIFICIAL MICROCAPSULES CONTAINING THALIDOMIDE FOR USE IN TREATING CROHN ' S DISEASE

  2013cites this paper
• Anti-inflammatory potential of artificial microcapsules containing thalidomide for use in treating Crohn's disease

  2013cites this paper
• Ethanol Extract of Cordyceps militaris Grown on Germinated Soybeans Attenuates Dextran-Sodium-Sulfate- (DSS-) Induced Colitis by Suppressing the Expression of Matrix Metalloproteinases and Inflammatory Mediators

  2013influential citation
• What is behind the non-antibiotic properties of minocycline?

  2013cites this paper
• The synthetic hydroxyproline-containing collagen analogue (Gly-Pro-Hyp)10 ameliorates acute DSS colitis.

  2012cites this paper
• Cucurbitacin L 2-O-β-Glucoside Demonstrates Apoptogenesis in Colon Adenocarcinoma Cells (HT-29): Involvement of Reactive Oxygen and Nitrogen Species Regulation

  2012cites this paper
• Minocycline in infammatory bowel disease: far beyond an antibiotic

  2012cites this paper
• An antagonist of human protease activated receptor‐2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen‐induced arthritis in rats

  2012cites this paper
• An Assessment of the Chondroprotective Effects of Intra-Articular Application of Statin and Tetracycline on Early-Stage Experimental Osteoarthritis

  2012cites this paper
• Upregulated Expression of Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinases in BALB/c Mouse Brain Challenged with Japanese Encephalitis Virus

  2012cites this paper
• Calcium-dependent potentiation of the pro-inflammatory functions of human neutrophils by tigecycline in vitro.

  2012cites this paper
• Minocycline Blocks Asthma-associated Inflammation in Part by Interfering with the T Cell Receptor-Nuclear Factor κB-GATA-3-IL-4 Axis without a Prominent Effect on Poly(ADP-ribose) Polymerase*

  2012cites this paper
• The distinct roles of MMP-2 and MMP-9 in acute DSS colitis.

  2011cites this paper
• Minocycline reduces ethanol drinking.

  2011cites this paper
• Inhibitor of PI3Kγ ameliorates TNBS‐induced colitis in mice by affecting the functional activity of CD4+CD25+FoxP3+ regulatory T cells

  2011cites this paper
• Role of Primed Microglia in the Aging Brain in Prolonged Sickness and Depressive Behavior Concomitant with Peripheral Immune Stimulation

  2011cites this paper
• The intestinal anti-inflammatory effect of minocycline in experimental colitis involves both its immunomodulatory and antimicrobial properties.

  2011cites this paper
• Selective gelatinase blockage ameliorates acute DSS colitis.

  2011cites this paper
• The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice.

  2011cites this paper
• THE ROLE OF GLIAL GLUTAMATE TRANSPORTER GLT-1 OVER-EXPRESSION IN MITIGATING VISCERAL NOCICEPTION

  2010cites this paper
• Minocycline differentially modulates macrophage mediated peripheral immune response following Japanese encephalitis virus infection.

  2010cites this paper
• Glutamine prevents fibrosis development in rats with colitis induced by 2,4,6-trinitrobenzene sulfonic acid.

  2010cites this paper
• Minocycline attenuates 5-fluorouracil-induced small intestinal mucositis in mouse model.

  2009cites this paper